Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changmao is a leading Chinese manufacturer of organic acids and related compounds, primarily for the food additive industry but also supplying pharmaceutical intermediates and excipients. The company’s products meet international quality standards (including US Pharmacopoeia and British Pharmacopoeia) and are certified Kosher, HALAL, ISO, HACCP, ISO14001, FSSC22000. Its L(+)-tartaric acid has GRAS status from the US FDA[2][5]. No clinical trial results are reported as the company does not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changmao Biochemical Engineering.